We sought to determine the course of the preclinical in preclinical Alzheimer's disease. On both preclinical measurement occasions, recall and recognition made episodic memory deficit in Alzheimer's disease. Using data from a population-based study, we compared persons independent contributions to group classification in logistic regression analyses. However, there was no who developed Alzheimer's disease (n ⍧ 15) with persons who were non-demented (n ⍧ 105) 6 and 3 years prior evidence for accelerated decline of episodic memory in the incident Alzheimer's disease group from 6 to 3 years to the diagnosis of dementia. Participants were tested on tasks assessing episodic memory (free recall and before diagnosis. These results indicate that Alzheimer's disease is characterized by a long preclinical period recognition of words) and short-term memory (digit span). The incident Alzheimer's disease cases performed more during which episodic memory deficits are detectable. The magnitude of these deficits appears to be quite stable, poorly than their non-demented counterparts both 3 and 6 years before diagnosis on recall and recognition. There at least up to 3 years before diagnosis. This may reflect the fact that those biological events that eventually result were no group differences in either forward or backward digit span. The selective impairment of episodic memory in clinically diagnosed Alzheimer's disease (e.g. the appearance of amyloid plaques and neurofibrillary before the diagnosis of Alzheimer's disease is consistent with the view that early changes in the hippocampal tangles) accumulate at a relatively slow rate. complex play an important role in the memory deficit
Introduction
Several reports have documented cognitive deficits in persons by having subjects recall or recognize some information encountered in the experimental setting (e.g. lists of words). who will develop Alzheimer's disease prior to diagnostically significant cognitive, behavioural and social changes (Masur Episodic memory deficits in persons who will develop Alzheimer's disease have been observed for both verbal et al., 1994; Jacobs et al., 1995; Small et al., 1997) . Such findings are vital in characterizing the insidious transition (Linn et al., 1995; Tierney et al., 1996) and non-verbal (Fuld et al., 1990; Small et al., 1997) materials, as well as in from normal ageing to dementia. Preclinical deficits in Alzheimer's disease have been demonstrated in multiple different retrieval conditions, including free recall (Howieson et al., 1997; Grober et al., 2000) , cued recall (Linn et al. , cognitive domains, including psychomotor speed (Masur et al., 1994) , verbal ability and reasoning (Jacobs et al., 1995; Bäckman and Small, 1998) and recognition (Fuld et al., 1990; Small et al., 1997) . The finding that episodic memory 1995) and visuospatial skill (Small et al., 1997) . However, the most pronounced and consistent cognitive deficits in deficits in preclinical Alzheimer's disease are marked and widespread is consistent with both histopathological (Braak preclinical Alzheimer's disease are seen for tasks assessing episodic memory (Hodges, 1998; Grober et al., 2000) . This and Braak, 1995; Van Hoesen et al., 1999) and morphological (Fox et al., 1996; Laakso et al., 1998) evidence that some form of memory involves conscious retrieval of information acquired in a particular place at a particular time (Tulving, of the earliest brain changes in this disease occur in the hippocampus and related structures. These regions have been 1983). In the laboratory, episodic memory is typically assessed strongly implicated in episodic memory in both lesion (Squire, 1987; Vargha-Khadem et al., 1997) and brain imaging Subjects (Nyberg et al., 1996; Schacter et al., 1996) studies.
Method
The study sample consisted of all subjects who were nonThe time between initial assessment and diagnosis in demented after the first follow-up and participated in the studies demonstrating preclinical memory deficits in second follow-up examination in the Kungsholmen Project. Alzheimer's disease typically ranges between 2 and 3 years,
The Kungsholmen Project has been approved by the ethics although such deficits have been documented for longer committee of the Karolinska Institute in Stockholm, Sweden, periods (Fuld et al., 1990; Yoshitake et al., 1995) . However, and written informed consent was obtained from all considerably less is known about the progression of memory participants after details of the procedure had been fully deficits before the diagnosis of Alzheimer's disease, as most explained. of the relevant studies have included only one preclinical
The original population included all inhabitants aged measurement point. There is evidence from both family-ജ75 years in the Kungsholmen parish of Stockholm (n ϭ based (Fox et al., 1998) and clinical (Rubin et al., 1998 (Rubin et al., ) 1810 . From this population, a subsample (n ϭ 524) was studies that patients in a preclinical phase of Alzheimer's selected to receive a comprehensive medical, social and disease exhibit a precipitous cognitive decline during the cognitive assessment (Bäckman et al., 1994) . Among the period just preceding diagnosis. Whether those who will persons who participated in the comprehensive assessment, develop Alzheimer's disease show disproportionate cognitive 189 had complete cognitive data and were non-demented at decline for a longer period before diagnosis remains unknown.
baseline and the first follow-up, which took place~3 years Such knowledge is important to further our understanding of later (mean 3.22 years, SD ϭ 0.52). A description of the the course of the early development of Alzheimer's disease. incident Alzheimer's disease cases at the first follow-up is The purpose of this research was to extend our knowledge provided elsewhere (Small et al., 1997) . During the 3-year concerning the course of the preclinical phase of Alzheimer's interval (mean 3.51 years, SD ϭ 0.44) between the first disease, with particular focus on memory functioning. Persons (Time 2) and second (Time 3) follow-up, 15 people were from a population-based study were examined on three diagnosed with possible or probable Alzheimer's disease, occasions over 6 years. On the last occasion, 15 individuals five were diagnosed with dementia of another type (e.g. were diagnosed with Alzheimer's disease, although the entire vascular dementia, mixed dementia), 51 died, 10 moved or study sample (n ϭ 120) was non-demented on the first two refused participation, one was eliminated because of a history occasions of measurement. This design enables comparison of psychiatric disturbance, two were excluded because of a of the accuracy of memory tests in predicting the development history of stroke, and 105 remained non-demented. The of Alzheimer's disease 3 and 6 years prior to diagnosis, persons who developed Alzheimer's disease and those who and the results provide novel information about whether remained non-demented between Time 2 and Time 3 preclinical Alzheimer's disease is characterized by constituted the groups of interest in the present study. accelerated memory decline for a relatively long time before
The diagnosis of dementia and dementia type followed a diagnosis. A related issue of interest is whether difference three-step diagnostic procedure at each time of measurement. scores for memory performance (i.e. score 6 years before
The presence of dementia and type of dementia was diagnosis minus score 3 year before diagnosis) are as effective determined according to DSM-III-R criteria (American as static performance scores in signalling an impending Psychiatric Association, 1987) with some modifications dementia disease. Unfortunately, missing data at the time of (Fratiglioni et al., 1992 (Fratiglioni et al., , 1997 . First, a preliminary diagnosis diagnosis precluded group comparisons of memory scores at was made by the examining physician. Secondly, all cases that time point.
were reviewed by a specialized clinician, and a second A final objective concerned the predictive accuracy of preliminary diagnosis was made. In cases of agreement different types of episodic memory tests. Evidence is mixed between the first and second diagnosis, this was the final with regard to which specific memory tests are most effective diagnosis; in cases of disagreement, the final diagnosis was in identifying those who will develop Alzheimer's disease.
made by a supervising physician. Neuroimaging was not part Some research suggests that tests that involve little support of the diagnostic process. The cognitive data reported in this at retrieval (e.g. free recall) are most predictive of incident article were not used for diagnostic purposes. Alzheimer's disease (Howieson et al., 1997) , whereas other Baseline (Time 1) background characteristics of the nonresearch suggests that more supported retrieval tests (e.g. demented participants and incident Alzheimer's disease cases recognition) are most effective (Small et al., 1997) . In this at the second follow-up are presented in non-demented persons. Specifically, we sought evidence for group differences both 6 and 3 years before diagnosis and those who would remain non-demented [F (1,118) ϭ 6.23, examined whether the incident Alzheimer's disease patients P Ͻ 0.05, η 2 ϭ 0.05]. There were no significant group would exhibit a disproportionate decline in memory differences (Ps Ͼ 0.05) in age, gender distribution, years of performance during the 3-year follow-up interval. Thus, education or functional status (Katz et al., 1963) .
three MANOVAs were conducted to investigate (i) group differences 6 years before diagnosis, (ii) group differences 3 years before diagnosis, and (iii) changes in memory
Measures of memory
performance during the 3-year follow-up period. As noted, there was a group difference in MMSE
Episodic memory
Two tasks were used to assess episodic memory: free recall performance at Time 1 favouring the non-demented persons (mean 28.07, SD ϭ 1.61) over the incident Alzheimer's and recognition of words (Bäckman and Forsell, 1994) . For free recall, two lists of 12 concrete nouns (e.g. child, pencil, disease cases (mean 26.93, SD ϭ 1.91). This difference in MMSE score remained at Time 2 [M ND ϭ 27.66, SD ϭ horse, bicycle) were prepared. All nouns in the lists belonged to different taxonomic categories. The lists were comparable 1.94; M IAD ϭ 25.67, SD ϭ 2.87 (M ϭ mean; ND ϭ nondemented persons; IAD ϭ persons with incident Alzheimer's in terms of the length, concreteness and imagery of the nouns, as determined by a previous normative study disease)]. To determine whether the potential effects of preclinical Alzheimer's disease on memory performance (Molander, 1984) . On each measurement occasion, approximately half of the participants received one list, were independent of group differences in global cognitive functioning, we repeated the MANOVAs described below whereas the other half received the other list. The specific list received varied among occasions. Participants were presented using the MMSE scores at Time 1 or Time 2 as covariates. The outcomes from these MANCOVAs (multivariate analyses with the words at a rate of one word every 5 s. The presentation was bimodal: the words were shown on cards and of covariance) were similar to those from the MANOVAs. Therefore, in this article we focus on the results from the the experimenter read them aloud simultaneously. Participants were instructed to remember as many words as possible for MANOVAs. The second set of analyses examined the ability of the the purpose of later recall. After the presentation of the last word in the series, participants free-recalled orally and the memory measures to predict who would develop Alzheimer's disease. In this case, logistic regression analyses were experimenter recorded their responses. Participants were given 2 min for the recall task. conducted with diagnostic category (i.e. incident Alzheimer's disease versus non-demented) as the outcome measure. After Immediately after the free-recall test, participants received a yes-no recognition test. Here, the 12 target items were controlling for demographic factors, the four memory measures (free recall of words, recognition of words, digit presented, together with 12 distractors that were intermixed randomly. Distractors were comparable with targets in word span forwards, digit span backwards) were entered in stepwise forward fashion. The memory measures were converted into length, concreteness and imagery (Molander, 1984) . Targets and distractors were presented consecutively in a booklet, standard (Z) scores before analysis. Thus, the resulting odds ratios represent differences in risk per standard deviation unit and the experimenter read the words aloud simultaneously. For each word, participants responded orally by indicating rather than per raw score unit. Three logistic regression analyses were conducted. First, the Time 1 memory whether the word had been presented before. Two minutes was also allowed for the recognition test (5 s per recognition performance scores were used as predictors in the equation. Secondly, the predictive power of the memory measures from judgement). To control for guessing, the outcome measure in this test was the difference between correct recognitions the second time of testing was examined. Thirdly, the utility of the Time 2 minus Time 1 difference scores as predictors (hits) and false alarms. was a large proportion of missing memory data in the incident Alzheimer's disease group at the time of diagnosis, we were 5.86, SD ϭ 1.14) or backward (M IAD ϭ 3.87, SD ϭ 1.51; unable to include the third testing occasion in the analysis M ND ϭ 4.17, SD ϭ 1.10) digit span (Ps Ͼ 0.30). of these data.
Next, mean-level changes in memory performance from 6 years (Time 1) to 3 years (Time 2) before diagnosis were examined. Table 2 
memory performance
To determine whether the lower episodic memory SD ϭ 1.12) or backward digit span (M IAD ϭ 4.33, SD ϭ 0.90; M ND ϭ 4.26, SD ϭ 1.06) (Ps Ͼ 0.30).
performance in preclinical cases of Alzheimer's disease was independent of age, education and gender, logistic regression The MANOVA on the cognitive data for the 3-year followup (Time 2) revealed the same pattern of results, with an analyses were conducted. In these analyses, the demographic factors were entered first as covariates. The results from the overall effect of group [Wilks λ ϭ 0.798, F(4,115) ϭ 7.29, P Ͻ 0.001], significant univariate differences for recall logistic regressions are shown in Table 3 . The first regression examined the predictive ability of the memory variables [F(1,118) ϭ 17.89, P Ͻ 0.001, η 2 ϭ 0.13] and recognition [F(1,118) ϭ 21.36, P Ͻ 0.001, η 2 ϭ 0.16], and no reliable measured 6 years before diagnosis (Time 1). In this analysis, both recall and recognition contributed reliably to the model, differences for forward (M IAD ϭ 5.60, SD ϭ 1.24; M ND ϭ whereas digit span was unrelated to the development of memory may not be observed in normal ageing over relatively short follow-up periods (Hultsch et al., 1992 ; Zelinski et al., Alzheimer's disease.
The second logistic regression model examined the 1997). The most intriguing result in this study was that not only the control subjects but also the incident Alzheimer's predictive ability of the 3-year memory measures (Time 2). The results were strikingly similar to those of the previous disease cases showed stability of episodic memory performance from 6 to 3 years prior to diagnosis. That is, analysis. Again, both recall and recognition made independent contributions, and the digit span measures did not contribute although they already exhibited clear deficits in the episodic memory tests at the first time of measurement, the incident to the model. The third regression model used the difference scores for Alzheimer's disease cases did not decline selectively between Time 1 and Time 2. In fact, the predictive accuracy for the the memory tests (Time 2 minus Time 1) as predictors. However, given that the mean-level analysis failed to memory variables was very similar at Time 1 and Time 2 ( Table 3) . As a result, the Time 2 minus Time 1 difference demonstrate differential change for the incident Alzheimer's disease group, thereby indicating approximately the same scores showed no predictive value in identifying those who would develop Alzheimer's disease. Thus, the present data difference scores for the two groups, it is not surprising that the difference scores were unrelated to subsequent suggest that the episodic memory deficit in preclinical Alzheimer's disease is characterized by an early onset dementia status.
followed by relative stability, at least until a few years before a diagnosis may be confirmed. Although a large amount of missing data in the incident Alzheimer's disease group
Discussion
The present results demonstrate impairment of episodic precluded an examination of memory performance at the time of diagnosis, several studies demonstrate precipitous memory in the preclinical phase of Alzheimer's disease Ͼ6 years prior to diagnosis (mean 6.73 years). This finding episodic memory decline during the final portion of the preclinical phase in Alzheimer's disease (Small et al., 1997; replicates and extends past observations (e.g. Fuld et al., 1990; Yoshitake et al., 1995; Fox et al., 1998) . The marked Fox et al., 1998; Rubin et al., 1998) .
The fact that memory impairment may be observed episodic memory deficit among those who would develop Alzheimer's disease can be contrasted with the complete Ͼ6 years before clinical diagnosis raises the issue of the actual onset of the preclinical phase of Alzheimer's disease. absence of group differences in short-term memory, as indexed by the digit span test. The lack of group differences Evidence from a study of nuns indicates that measures of linguistic skill assessed when participants were approximately in backward digit span is especially noteworthy, given that this test requires temporal reorganization of digits, and 20 years of age were highly predictive of who would develop Alzheimer's disease more than 50 years later (Snowdon et al., thus poses demands on working memory (Baddeley, 1992) . Deficits in working memory are routinely observed in early 1996). Related to this, histopathological data show that initial signs of the formation of neurofibrillary tangles (i.e. clinical Alzheimer's disease (Baddeley et al., 1986; Morris, 1986) . However, the present data suggest that such deficits cytoskeletal changes) may already emerge in the transentorhinal cortex in early adulthood (Braak et al., 1993) . may not be observed preclinically, at least when using backward digit span as the criterion test. This may reflect Considering these observations together with those of the present study, it would appear that the neural changes the fact that those prefrontal brain structures known to be critical to working memory functioning (Cabeza and Nyberg, eventually leading to clinical Alzheimer's disease progress at a very slow rate, and that accelerated memory decline 2000) are relatively little affected in the preclinical phase of Alzheimer's disease (Braak and Braak, 1991) .
may not be expected until various biological processes (e.g. the formation of neurofibrillary tangles and amyloid plaques) The pattern of results obtained for episodic and short-term memory indicates that persons in a preclinical phase of have reached a certain threshold. Relevant to this argument are also recent findings that deleterious socioeconomic and Alzheimer's disease have special difficulties in transferring information from a temporary to a more permanent environmental influences early in life may increase the risk of developing Alzheimer's disease in late life (Hall et al., representation, although the ability to hold information for a relatively brief period is well preserved (Bäckman and Small, 2000; Moceri et al., 2000) . Unfortunately, we lack data on cognitive performance for the present participants prior to 1998). There is converging evidence that the hippocampus and neighbouring regions are critical in establishing new their entry into the study. Thus, we are unable to address empirically the issue of a potential lifelong course of the episodic memory representations (Nyberg et al., 1996; Vargha-Khadem et al., 1997) . Thus, it is conceivable that preclinical phase of Alzheimer's disease. However, as noted above, research suggests that this phase may start earlier in early changes in the hippocampal complex (Braak and Braak, 1995; Fox et al., 1996) play a major role in the episodic life than previously thought. Another interesting observation was that tests of free recall memory deficit observed in preclinical Alzheimer's disease.
The finding that the normal old persons remained stable and recognition alike were effective in discriminating between the two groups both 6 and 3 years before diagnosis. Several during the retest interval is consistent with the results from several longitudinal studies, indicating that decline in episodic points should be made concerning the similar efficacy of 1993; 19: 228. directly the present recall and recognition data because of differences in task difficulty, the qualitatively similar patterns should be highlighted (Fig. 1) . This result indicates that indicating a potential for memory improvement in this phase of the disease (Bäckman and Small, 1998) . It has been argued cases (Petersen et al., 1999) . Knowing that there is room for 
